VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 189 filers reported holding VANDA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.80 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $30,000 | -9.1% | 3,000 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $33,000 | -2.9% | 3,000 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $34,000 | -27.7% | 3,000 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $47,000 | -7.8% | 3,000 | 0.0% | 0.00% | -25.0% |
| Q3 2021 | $51,000 | -21.5% | 3,000 | 0.0% | 0.00% | -20.0% |
| Q2 2021 | $65,000 | -13.3% | 3,000 | -40.0% | 0.01% | -28.6% |
| Q1 2021 | $75,000 | +13.6% | 5,000 | 0.0% | 0.01% | 0.0% |
| Q4 2020 | $66,000 | +37.5% | 5,000 | 0.0% | 0.01% | +16.7% |
| Q3 2020 | $48,000 | -15.8% | 5,000 | 0.0% | 0.01% | -14.3% |
| Q2 2020 | $57,000 | +9.6% | 5,000 | 0.0% | 0.01% | -12.5% |
| Q1 2020 | $52,000 | -36.6% | 5,000 | 0.0% | 0.01% | -11.1% |
| Q4 2019 | $82,000 | +24.2% | 5,000 | 0.0% | 0.01% | +28.6% |
| Q3 2019 | $66,000 | -28.3% | 5,000 | 0.0% | 0.01% | -36.4% |
| Q1 2019 | $92,000 | -29.8% | 5,000 | 0.0% | 0.01% | -35.3% |
| Q4 2018 | $131,000 | +13.9% | 5,000 | 0.0% | 0.02% | +30.8% |
| Q3 2018 | $115,000 | +21.1% | 5,000 | 0.0% | 0.01% | +18.2% |
| Q2 2018 | $95,000 | +13.1% | 5,000 | 0.0% | 0.01% | +10.0% |
| Q1 2018 | $84,000 | +10.5% | 5,000 | 0.0% | 0.01% | +11.1% |
| Q4 2017 | $76,000 | -15.6% | 5,000 | 0.0% | 0.01% | -18.2% |
| Q3 2017 | $90,000 | +9.8% | 5,000 | 0.0% | 0.01% | 0.0% |
| Q2 2017 | $82,000 | +17.1% | 5,000 | 0.0% | 0.01% | +10.0% |
| Q1 2017 | $70,000 | -12.5% | 5,000 | 0.0% | 0.01% | -16.7% |
| Q4 2016 | $80,000 | -3.6% | 5,000 | 0.0% | 0.01% | -20.0% |
| Q3 2016 | $83,000 | +48.2% | 5,000 | 0.0% | 0.02% | +50.0% |
| Q2 2016 | $56,000 | +33.3% | 5,000 | 0.0% | 0.01% | +25.0% |
| Q1 2016 | $42,000 | -10.6% | 5,000 | 0.0% | 0.01% | -11.1% |
| Q4 2015 | $47,000 | -16.1% | 5,000 | 0.0% | 0.01% | -25.0% |
| Q3 2015 | $56,000 | -11.1% | 5,000 | 0.0% | 0.01% | 0.0% |
| Q2 2015 | $63,000 | +37.0% | 5,000 | 0.0% | 0.01% | +33.3% |
| Q1 2015 | $46,000 | -36.1% | 5,000 | 0.0% | 0.01% | -35.7% |
| Q4 2014 | $72,000 | +38.5% | 5,000 | 0.0% | 0.01% | +40.0% |
| Q3 2014 | $52,000 | -35.8% | 5,000 | 0.0% | 0.01% | -37.5% |
| Q2 2014 | $81,000 | 0.0% | 5,000 | 0.0% | 0.02% | -5.9% |
| Q1 2014 | $81,000 | – | 5,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Signpost Capital Advisors, LP | 1,688,952 | $27,327,000 | 10.37% |
| Palo Alto Investors LP | 3,240,424 | $52,430,000 | 3.90% |
| Parametrica Management Ltd | 12,509 | $202,000 | 1.53% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,740,400 | $28,160,000 | 1.08% |
| PACIFIC ALTERNATIVE ASSET MANAGEMENT COMPANY, LLC | 557,100 | $9,014,000 | 1.07% |
| Westend Capital Management, LLC | 64,086 | $841,000 | 1.00% |
| WALL STREET ASSOCIATES | 702,700 | $11,370,000 | 0.98% |
| Baker Brothers Advisors | 4,372,153 | $70,741,000 | 0.87% |
| Iguana Healthcare Management, LLC | 100,000 | $1,618,000 | 0.76% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,085,301 | $17,560,000 | 0.71% |